exRNAdisease

Entry Detail

---



General Information

Database ID: exR0755796 RNA Name: APP RNA Type: mRNA Chromosome: chr21 Starnd: - Coordinate: Start Site(bp): 25880550 End Site(bp): 26171128 External Links: ENSG00000142192

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ABCF2 chr7 151207837 151227166 - ABRACL chr6 139028745 139043302 + AC008695.1 chr5 131425891 131796983 - AC012254.2 chr18 47108188 47176345 - AC093525.2 chr16 2496032 2520218 + AC138811.2 chr16 18788063 18801519 - AC245033.1 chr15 82536788 82573194 - ACAA2 chr18 49782164 49813953 - ACTB chr7 5527148 5563784 - ACTG1 chr17 81509971 81523847 - ACTR10 chr14 58200080 58235636 + ADAR chr1 154582057 154628013 - ADI1 chr2 3497366 3519531 - ADK chr10 74151202 74709963 + AGL chr1 99850361 99924023 + AGPAT1 chr6 32168212 32178096 - AHNAK chr11 62433542 62556235 - AIF1L chr9 131096476 131123152 + AKIRIN1 chr1 38991276 39006059 + AL133352.1 chr10 100505628 100529881 - AL136454.1 chr1 192716132 192716653 + AL139011.2 chr1 160216800 160285130 - AL355916.3 chr14 61529128 61657964 + AL589666.1 chr6 85557978 85615234 - ALAS1 chr3 52198086 52214327 + ALDOA chr16 30064164 30070457 + miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-17-5p chr13 91350618 91350640 + hsa-miR-20a-5p chr13 91351072 91351094 + hsa-miR-21-5p chr17 59841273 59841294 + hsa-miR-29a-3p chr7 130876748 130876769 - hsa-miR-29b-3p chr7 130877467 130877489 - hsa-miR-106a-5p chrX 134170244 134170266 - hsa-miR-214-3p chr1 172138816 172138837 - hsa-miR-106b-5p chr7 100094043 100094063 - hsa-miR-29c-3p chr1 207801865 207801886 - hsa-miR-302a-3p chr4 112648186 112648208 - hsa-miR-302c-3p chr4 112648366 112648388 - hsa-miR-373-3p chr19 53788748 53788770 + hsa-miR-20b-5p chrX 134169850 134169872 - hsa-miR-520e-3p chr19 53675764 53675784 + hsa-miR-520a-3p chr19 53690933 53690954 + hsa-miR-520b-3p chr19 53701267 53701287 + hsa-miR-520c-3p chr19 53707506 53707527 + hsa-miR-520d-3p chr19 53720149 53720170 + hsa-miR-4426 chr1 192716333 192716349 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC016876.2 chr17 7581964 7584086 - AC021078.1 chr5 149494314 149504670 - AC023509.1 chr12 53441741 53467528 + AC024940.6 chr12 31280422 31280895 - Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.